Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Copenhagen University Hospital, Rigshospitalet: Clinical Trials & FDA Approval Profile

Copenhagen University Hospital, Rigshospitalet (Global / Institutional) sponsors 35 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 17 active protocols (10 recruiting now), 8 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)2.9%
Median Closed Enrollment vs National (145 pts)63 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Copenhagen University Hospital, Rigshospitalet
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)35
Active Pipeline (Recruiting Now)17 (10)
Completed vs Stopped Early8 / 1 (2.9%)
Median Closed Actual Enrollment63 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Copenhagen University Hospital, Rigshospitalet
Hospital Research SiteLocationShared Protocols
RigshospitaletCopenhagen9

Explore interactive annual charts and M&A subsidiary rollups in the Copenhagen University Hospital, Rigshospitalet Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI